Ultra Seal Corporation recalls Exaprin pain reliever (acetaminophen 110 mg, aspirin 162 mg, caffeine 32.4mg, salicylamide 152mg) tablets, 2- tablet pa
Recalled February 9, 2022 · FDA recall D-0507-2022 · Ultra Seal
Hazard
cGMP deviations · FDA Class II
Units
1,1401,641 packets
Sold at
Nationwide within the United States
Description
cGMP deviations
Product
Exaprin pain reliever (acetaminophen 110 mg, aspirin 162 mg, caffeine 32.4mg, salicylamide 152mg) tablets, 2- tablet packets, Manufactured for: HARTHealth Seattle, WA 98124
Manufacturer(s)
Ultra Seal Corporation
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →